Survival Outcomes of Two Phase 2 Studies of Adjuvant Chemotherapy with S-1 Plus Oxaliplatin or Capecitabine Plus Oxaliplatin for Patients with Gastric Cancer After D2 Gastrectomy

被引：0
作者：
Yoshiaki Nakamura
Takeharu Yamanaka
Keisho Chin
Haruhiko Cho
Hitoshi Katai
Masanori Terashima
Kazunari Misawa
Motohiro Hirao
Kazuhiro Yoshida
Eiji Oki
Mitsuru Sasako
Yasunori Emi
Hideaki Bando
Yoshiyuki Kawashima
Tetsu Fukunaga
Masahiro Gotoh
Takako Ishibashi
Kohei Shitara
机构：
[1] National Cancer Center Hospital East,Department of Gastroenterology and Gastrointestinal Oncology
[2] Yokohama City University,Department of Biostatistics
[3] Cancer Institute Hospital of Japanese Foundation for Cancer Research,Department of Gastroenterology
[4] Kanagawa Cancer Center,Department of Gastrointestinal Surgery
[5] Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital,Department of Surgery
[6] National Cancer Center Hospital,Division of Gastric Surgery
[7] Shizuoka Cancer Center,Division of Gastric Surgery
[8] Aichi Cancer Center Hospital,Department of Gastroenterological Surgery
[9] National Hospital Organization Osaka National Hospital,Department of Surgery
[10] Gifu University,Department of Surgical Oncology, Graduate School of Medicine
[11] Kyushu University Hospital,Department of Surgery and Science, Graduate School of Medical Sciences
[12] Hyogo College of Medicine,Department of Surgery
[13] Saiseikai Fukuoka General Hospital,Department of Surgery
[14] Saitama Cancer Center,Department of Gastroenterological Surgery
[15] St. Marianna University School of Medicine,Department of Gastroenterological and General Surgery
[16] Osaka Medical College,Cancer Chemotherapy Center
[17] Yokohama City University Hospital,Center for Novel and Exploratory Clinical Trials
来源：
Annals of Surgical Oncology | 2019年 / 26卷
关键词：
Capecitabine Plus Oxaliplatin (CAPOX); Survival Outcomes; Gastric Cancer; pStage; Histological Type;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：465 / 472
页数：7
相关论文
共 50 条
[21]   Oxaliplatin plus S-1 or capecitabine as neoadjuvant or adjuvant chemotherapy for locally advanced gastric cancer with D2 lymphadenectomy: 5-year follow-up results of a phase II-III randomized trial [J].
Xue, Kan ;
Ying, Xiangji ;
Bu, Zhaode ;
Wu, Aiwen ;
Li, Zhongwu ;
Tang, Lei ;
Zhang, Lianhai ;
Zhang, Yan ;
Li, Ziyu ;
Ji, Jiafu .
CHINESE JOURNAL OF CANCER RESEARCH, 2018, 30 (05) :516-+
[22]   CYP2A6 Polymorphisms Associate with Outcome of S-1 Plus Oxaliplatin Chemotherapy in Chinese Gastric Cancer Patients [J].
Lin Yang ;
Shanshan Zou ;
Chang Shu ;
Yan Song ;
YongKun Sun ;
Wen Zhang ;
Aiping Zhou ;
Xinghua Yuan ;
Yi Yang ;
Songnian Hu .
Genomics,Proteomics & Bioinformatics, 2017, (04) :255-262
[23]   Author response to comment on "Phase 2 study of neoadjuvant durvalumab plus docetaxel, oxaliplatin, and S-1 with surgery and adjuvant durvalumab plus S-1 for resectable locally advanced gastric cancer" [J].
Kim, Hyung-Don ;
Ryu, Min-Hee ;
Kang, Yoon-Koo .
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2025, 13 (05)
[24]   A randomized phase III trial comparing adjuvant single-agent S1, S-1 with oxaliplatin, and postoperative chemoradiation with S-1 and oxaliplatin in patients with node-positive gastric cancer after D2 resection: the ARTIST 2 trial [J].
Park, S. H. ;
Lim, D. H. ;
Sohn, T. S. ;
Lee, J. ;
Zang, D. Y. ;
Kim, S. T. ;
Kang, J. H. ;
Oh, S. Y. ;
Hwang, I. G. ;
Ji, J. H. ;
Shin, D. B. ;
Yu, J., I ;
Kim, K-M ;
An, J. Y. ;
Choi, M. G. ;
Lee, J. H. ;
Kim, S. ;
Hong, J. Y. ;
Park, J. O. ;
Park, Y. S. ;
Lim, H. Y. ;
Bae, J. M. ;
Kang, W. K. .
ANNALS OF ONCOLOGY, 2021, 32 (03) :368-374
[25]   Long-Term Survival Outcomes of Elderly Patients Treated With S-1 or Capecitabine Plus Oxaliplatin for Stage II or III Gastric Cancer: A Multicenter Cohort Study [J].
Choi, Seohee ;
Min, Jae-Seok ;
Jeong, Sang-Ho ;
Yoo, Moon-Won ;
Son, Young-Gil ;
Oh, Sung Jin ;
Kim, Jong-Han ;
Park, Joong-Min ;
Hur, Hoon ;
Jee, Ye Seob ;
Hwang, Sun-Hwi ;
Jin, Sung-Ho ;
Lee, Sang Eok ;
Lee, Young-Joon ;
Seo, Kyung Won ;
Park, Sungsoo ;
Lee, Chang Min ;
Kim, Chang Hyun ;
Jeong, In Ho ;
Lee, Han Hong ;
Choi, Sung Il ;
Lee, Sang-Il ;
Kim, Chan-Young ;
Chae, Hyundong ;
Son, Myoung-Won ;
Pak, Kyung Ho ;
Kim, Sungsoo ;
Lee, Moon-Soo ;
Kim, Hyoung-Il .
JOURNAL OF GASTRIC CANCER, 2022, 22 (01) :67-77
[26]   Impact of progression type on overall survival in patients with advanced gastric cancer based on randomized phase III study of S-1 plus oxaliplatin versus S-1 plus cisplatin [J].
Kazuhiro Nishikawa ;
Yasuhide Yamada ;
Kenji Ishido ;
Masahiro Gotoh ;
Hideaki Bando ;
Naotoshi Sugimoto ;
Tomohiro Nishina ;
Kenji Amagai ;
Keisho Chin ;
Yasumasa Niwa ;
Akihito Tsuji ;
Hiroshi Imamura ;
Masahiro Tsuda ;
Hirofumi Yasui ;
Hirofumi Fujii ;
Kensei Yamaguchi ;
Hisateru Yasui ;
Shuichi Hironaka ;
Ken Shimada ;
Hiroto Miwa ;
Chikuma Hamada ;
Ichinosuke Hyodo .
Gastric Cancer, 2017, 20 :640-645
[27]   Long-term Efficacy of S-1 Monotherapy or Capecitabine Plus Oxaliplatin as Adjuvant Chemotherapy for Patients with Stage II or III Gastric Cancer after Curative Gastrectomy: a Propensity Score-Matched Multicenter Cohort Study [J].
Lee, Chang Min ;
Yoo, Moon-Won ;
Son, Young-Gil ;
Oh, Sung Jin ;
Kim, Jong-Han ;
Kim, Hyoung-Il ;
Park, Joong-Min ;
Hur, Hoon ;
Jee, Ye Seob ;
Hwang, Sun-Hwi ;
Jin, Sung-Ho ;
Lee, Sang Eok ;
Park, Ji-Ho ;
Seo, Kyung Won ;
Park, Sungsoo ;
Kim, Chang Hyun ;
Jeong, In Ho ;
Lee, Han Hong ;
Choi, Sung Il ;
Lee, Sang-Il ;
Kim, Chan Young ;
Kim, In-Hwan ;
Son, Myoung-Won ;
Pak, Kyung Ho ;
Kim, Sungsoo ;
Lee, Moon-Soo ;
Min, Jae-Seok .
JOURNAL OF GASTRIC CANCER, 2020, 20 (02) :152-164
[28]   Impact of progression type on overall survival in patients with advanced gastric cancer based on randomized phase III study of S-1 plus oxaliplatin versus S-1 plus cisplatin [J].
Nishikawa, Kazuhiro ;
Yamada, Yasuhide ;
Ishido, Kenji ;
Gotoh, Masahiro ;
Bando, Hideaki ;
Sugimoto, Naotoshi ;
Nishina, Tomohiro ;
Amagai, Kenji ;
Chin, Keisho ;
Niwa, Yasumasa ;
Tsuji, Akihito ;
Imamura, Hiroshi ;
Tsuda, Masahiro ;
Yasui, Hirofumi ;
Fujii, Hirofumi ;
Yamaguchi, Kensei ;
Yasui, Hisateru ;
Hironaka, Shuichi ;
Shimada, Ken ;
Miwa, Hiroto ;
Hamada, Chikuma ;
Hyodo, Ichinosuke .
GASTRIC CANCER, 2017, 20 (04) :640-645
[29]   Conversion surgery after S-1 plus oxaliplatin combination chemotherapy for advanced gastric cancer with multiple liver metastases [J].
Namikawa T. ;
Tsuda S. ;
Fujisawa K. ;
Iwabu J. ;
Uemura S. ;
Tsujii S. ;
Maeda H. ;
Kitagawa H. ;
Kobayashi M. ;
Hanazaki K. .
Clinical Journal of Gastroenterology, 2018, 11 (4) :297-301
[30]   Health-Related Quality of Life in Patients With Locally Advanced Gastric Cancer Undergoing Perioperative or Postoperative Adjuvant S-1 Plus Oxaliplatin With D2 Gastrectomy: A Propensity Score-Matched Cohort Study [J].
Yu, Jianhong ;
Wang, Zaozao ;
Li, Zhexuan ;
Liu, Ying ;
Fan, Yingcong ;
Di, Jiabo ;
Cui, Ming ;
Xing, Jiadi ;
Zhang, Chenghai ;
Yang, Hong ;
Yao, Zhendan ;
Zhang, Nan ;
Chen, Lei ;
Liu, Maoxing ;
Xu, Kai ;
Tan, Fei ;
Gao, Pin ;
Su, Xiangqian .
FRONTIERS IN ONCOLOGY, 2022, 12
12345